Building Your Understanding of FFEVF1 and DEPDC5

Learning that your family carries a genetic variant for epilepsy can be overwhelming, especially when the condition looks different in every person it affects. Familial Focal Epilepsy with Variable Foci 1 (FFEVF1) is a rare, inherited form of epilepsy that often defies a single description ^[1]. It is primarily linked to pathogenic variants in the DEPDC5 gene, which acts as a “brake” on a growth pathway in the brain called mTOR ^[2][3]. When this brake is missing or weakened due to a genetic change, brain cells can become overactive, leading to seizures ^[4].

It is completely normal to feel confused or anxious when a “family condition” seems to have no consistent pattern. In FFEVF1, one family member might have mild seizures, while another might face seizures that are difficult to control with standard medications ^[5][4]. Understanding how this gene works and why it behaves so differently can help you navigate these uncertainties.

The Meaning of Variable Foci

The term variable foci is the defining characteristic of this condition. FFEVF1 is unusual because the “focus” (the starting point of the seizure) can vary significantly from person to person within the same family ^[1][6].

For example, in one family:

• A father might have occipital seizures, which start in the back of the brain and may cause visual changes.
• His daughter might have frontal lobe seizures, which often happen during sleep and involve sudden, complex movements.
• Another relative might have seizures starting in the temporal lobe, affecting memory or emotions ^[7].

This variability happens because the DEPDC5 variant creates a general “susceptibility” to seizures rather than a single, fixed defect ^[8]. In some cases, a person may develop a small area of abnormal brain structure called focal cortical dysplasia (FCD), which serves as the focus for their seizures, while other family members have completely normal brain imaging ^[9][7].

Understanding Incomplete Penetrance

One of the most important concepts in FFEVF1 is incomplete penetrance. This means that carrying the genetic variant does not guarantee that a person will develop epilepsy ^[5].

If a parent carries a heterozygous pathogenic DEPDC5 variant, each biological child generally has a 50% chance of inheriting the variant. However, current research in some cohorts suggests a penetrance rate of approximately 68% ^[5][7]. This means only a portion of people with the variant will ever experience a seizure, and this rate depends on the family and the variant. Because of this, you may find “skipped generations” where a parent has the gene but no seizures. Alternatively, a variant can occur de novo (spontaneously) without being inherited ^[10]. Approximately 76% of those who do develop epilepsy in some studies had their first seizure by age 10 ^[7]. A genetic counselor can provide individualized risk interpretation.

A Wide Range of Outcomes

The severity of FFEVF1 varies significantly, even among relatives. Outcomes generally fall into three categories:

1. Asymptomatic Carriers: These individuals have the gene but never experience seizures ^[5].
2. Remission with Treatment: Some people develop seizures in childhood that are controlled with medication and may eventually go into remission. (Note: Do not stop taking medication without a doctor’s supervision). In one small study, a subset of patients showed a tendency toward this kind of improvement ^[4].
3. Drug-Resistant Epilepsy: Some individuals (roughly 21% to 48% in some clinical reviews) have seizures that do not respond well to standard anti-seizure drugs ^[7][11].

For those with drug-resistant epilepsy, brain surgery may be an option if a specific seizure focus (like FCD) can be identified. Studies have shown that many people who undergo surgery for DEPDC5-related epilepsy have favorable outcomes ^[7].

Monitoring and Care

Because the condition is so variable, there is no “one-size-fits-all” plan for family members. If a family member carries the gene but has no symptoms, doctors typically do not recommend starting preventive medication ^[12]. Instead, care usually focuses on:

• Observation: Watching for subtle signs like staring spells, sudden nighttime jerks, or unusual sensory experiences ^[13].
• Developmental Support: Most individuals have typical cognition, but a subset may face learning or behavioral challenges. Routine screening is advised ^[2].
• Genetic Counseling: Helping family members understand their personal risks ^[10].

While the unpredictability of FFEVF1 can be stressful, knowing that many carriers lead healthy, seizure-free lives can provide a sense of balance as you manage your family’s health ^[4][5].